Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.

Lan YY, De Creus A, Colvin BL, Abe M, Brinkmann V, Coates PT, Thomson AW.

Am J Transplant. 2005 Nov;5(11):2649-59.

2.

Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.

Lan YY, Tokita D, Wang Z, Wang HC, Zhan J, Brinkmann V, Thomson AW.

Transpl Immunol. 2008 Nov;20(1-2):88-94. doi: 10.1016/j.trim.2008.07.004. Epub 2008 Aug 9.

PMID:
18694829
4.

Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.

Gollmann G, Neuwirt H, Tripp CH, Mueller H, Konwalinka G, Heufler C, Romani N, Tiefenthaler M.

Int Immunol. 2008 Jul;20(7):911-23. doi: 10.1093/intimm/dxn050. Epub 2008 May 20.

PMID:
18495625
5.

The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.

Sawicka E, Dubois G, Jarai G, Edwards M, Thomas M, Nicholls A, Albert R, Newson C, Brinkmann V, Walker C.

J Immunol. 2005 Dec 15;175(12):7973-80.

6.

Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.

Maeda Y, Seki N, Sato N, Sugahara K, Chiba K.

Int Immunol. 2010 Jun;22(6):515-25. doi: 10.1093/intimm/dxq036. Epub 2010 May 23.

PMID:
20497959
7.

FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.

Hofmann M, Brinkmann V, Zerwes HG.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1902-10. Epub 2006 Aug 30.

PMID:
17161343
9.
10.

The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.

Wolf AM, Eller K, Zeiser R, Dürr C, Gerlach UV, Sixt M, Markut L, Gastl G, Rosenkranz AR, Wolf D.

J Immunol. 2009 Sep 15;183(6):3751-60. doi: 10.4049/jimmunol.0901011. Epub 2009 Aug 19.

11.

The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.

Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, Bruns CJ, Jauch KW, Heeschen C, Graeb C.

J Cell Biochem. 2007 May 1;101(1):259-70.

PMID:
17203465
12.

Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.

Idzko M, Hammad H, van Nimwegen M, Kool M, Müller T, Soullié T, Willart MA, Hijdra D, Hoogsteden HC, Lambrecht BN.

J Clin Invest. 2006 Nov;116(11):2935-44.

13.
14.

The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.

von Wenckstern H, Zimmermann K, Kleuser B.

Arch Immunol Ther Exp (Warsz). 2006 Jul-Aug;54(4):239-51. Epub 2006 Jul 10. Review.

PMID:
16830220
15.

Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.

Morris MA, Gibb DR, Picard F, Brinkmann V, Straume M, Ley K.

Eur J Immunol. 2005 Dec;35(12):3570-80.

16.

The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells.

Müller H, Hofer S, Kaneider N, Neuwirt H, Mosheimer B, Mayer G, Konwalinka G, Heufler C, Tiefenthaler M.

Eur J Immunol. 2005 Feb;35(2):533-45.

17.

CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720.

Henning G, Ohl L, Junt T, Reiterer P, Brinkmann V, Nakano H, Hohenberger W, Lipp M, Förster R.

J Exp Med. 2001 Dec 17;194(12):1875-81.

18.

A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.

Quesniaux V, Fullard L, Arendse H, Davison G, Markgraaff N, Auer R, Ehrhart F, Kraus G, Schuurman HJ.

Transpl Immunol. 1999 Sep;7(3):149-57.

PMID:
10608298
19.

Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.

Chiba K, Matsuyuki H, Maeda Y, Sugahara K.

Cell Mol Immunol. 2006 Feb;3(1):11-9. Review.

20.

FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release.

Rolin J, Sand KL, Knudsen E, Maghazachi AA.

Cancer Immunol Immunother. 2010 Apr;59(4):575-86. doi: 10.1007/s00262-009-0775-7. Epub 2009 Oct 13.

PMID:
19823820

Supplemental Content

Support Center